Promising MS drug may worsen disease, research suggests (IMAGE)
Caption
Alban Gaultier, PhD, of the University of Virginia School of Medicine, has concluded that a promising MS drug may worsen the disease in people.
Credit
Dan Addison | UVA Communications
Usage Restrictions
May be used to accompany news coverage of the MS findings. All other uses require express written permission from UVA Health.
License
Licensed content